About IMQUEST BIOSCIENCES, INC.
ImQuest BioSciences is a preclinical and infectious disease CRO that provides expert services to evaluate novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer, and inflammatory diseases. They offer comprehensive compound screening, drug target validation, and toxicity evaluations for a diverse client portfolio.
Comprehensive compound screening to define target efficacyDrug target validation, mechanism of action, drug combination and toxicity evaluationsServices for small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies, and vaccinesDiverse viral panels and decades of antiviral expertiseCustom cell-based assays and immune and cytokine analysisAntibacterial and antifungal testing with in vitro and in vivo servicesCell-based anticancer screening service with diverse cell panelsFull service, customizable R&D for molecular biology
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Health and Human Services | $16K | |
| Federal contract award | Department of Health and Human Services | $72K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to IMQUEST BIOSCIENCES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.